Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Encephalitis
Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis
April 15th, 2009
Intercell AG (VSE: ICLL) announced FDA approval of its new vaccine, IXIARO, for the prevention of Japanese Encephalitis (JE), which now builds the basis for the future distribution of the vaccine to the U.S. military. The Defense Logistics Agency (DLA), United States Department of Defense, already posted a Request for Proposal (RFP) for purchase of JE vaccine in August 2008. As JE is a serious and growing public health threat in Asia, the DLA intends to enter into a contract to purchase supplies of JE vaccine for use with military personnel who are deployed to affected countries. "With the approval of IXIARO, Americans - both civilians and military personnel - will have...
Source: Vaccine Weekly (2009-04-15)
|
